Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma

Figure 2

Heatmap and volcano of (a) differential genes, (b) differential immune-related genes, and (c) differential TFs between tumor and normal samples. Forest plots of hazard ratios of 24 immune-related genes with prognostic ability (d). Network of interaction between differential immune-related genes and TFs (e).

(a)

(b)

(c)

(d)

(e)